Position in SERA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,785
-$59,108 QoQ
Shares Held
3,179
-90.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 46 holders
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SERA Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,820,800,481 across 112 Medical Devices names. SERA ranks #85 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
6,084,725 | $476,008,034 | |
| 2 | ABT |
Abbott Laboratories
|
3,863,474 | $350,571,627 | |
| 3 | SYK |
Stryker Corp
|
805,637 | $253,646,750 | |
| 4 | BSX |
Boston Scientific Corp
|
4,584,260 | $195,656,215 | |
| 5 | BIO |
Bio-Rad Laboratories, Inc.
|
267,634 | $78,580,018 | |
| 6 | EW |
Edwards Lifesciences Corp
|
775,100 | $70,115,545 | |
| 7 | DXCM |
Dexcom Inc
|
999,563 | $67,320,565 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
913,578 | $58,478,126 |
All Filings in SERA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,785 | 3,179 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $64,893 | 31,967 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $108,329 | 36,722 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $30,587 | 9,996 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $5 | 2 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $114,374 | 31,080 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $364,037 | 44,722 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $307,710 | 39,450 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $55,393 | 9,357 | Shares | Sole | 2026-03-23 | |
| 2022-03-31 | $4,862 | 1,283 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||